MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 135 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,162,000 | -36.8% | 28,500 | 0.0% | 0.01% | -37.5% |
| Q2 2023 | $6,584,000 | -4.6% | 28,500 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $6,904,000 | -16.5% | 28,500 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $8,272,000 | +331.5% | 28,500 | -2.9% | 0.01% | +400.0% |
| Q3 2022 | $1,917,000 | -9.2% | 29,349 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $2,111,000 | -27.1% | 29,494 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,894,000 | +15.8% | 29,494 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,499,000 | +6.2% | 29,494 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,353,000 | -16.0% | 29,494 | +2.6% | 0.00% | 0.0% |
| Q2 2021 | $2,800,000 | -16.7% | 28,751 | 0.0% | 0.00% | -60.0% |
| Q1 2021 | $3,363,000 | +5.0% | 28,751 | -0.2% | 0.01% | 0.0% |
| Q4 2020 | $3,204,000 | -6.4% | 28,820 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $3,422,000 | +4.8% | 28,820 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $3,264,000 | +71.5% | 28,820 | +1.1% | 0.01% | +50.0% |
| Q1 2020 | $1,903,000 | -26.7% | 28,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,597,000 | +5.7% | 28,500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,457,000 | -72.6% | 28,500 | -66.7% | 0.00% | -20.0% |
| Q2 2019 | $8,961,000 | +76.2% | 85,500 | +110.6% | 0.01% | -44.4% |
| Q1 2019 | $5,086,000 | +15.4% | 40,600 | +3.8% | 0.01% | 0.0% |
| Q4 2018 | $4,407,000 | -37.1% | 39,100 | +19.6% | 0.01% | -18.2% |
| Q3 2018 | $7,002,000 | +5.2% | 32,700 | +37.4% | 0.01% | 0.0% |
| Q2 2018 | $6,657,000 | – | 23,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |